title: Target-treatment and patients' selection: can we still neglect the timing of tissue collection?
authors.forename: Tommaso
authors.initials: T
authors.lastname: De Pas
authors.forename: Carlo
authors.initials: C
authors.lastname: Putzu
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Pelosi
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Curigliano
authors.forename: Cristina
authors.initials: C
authors.lastname: Noberasco
authors.forename: Giulia
authors.initials: G
authors.lastname: Zampino
authors.forename: Nicola
authors.initials: N
authors.lastname: Fazio
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Formica
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Spaggiari
authors.forename: Filippo
authors.initials: F
authors.lastname: de Braud
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000188:drug therapy; D066246:ErbB Receptors / Q000096:biosynthesis / Q000145:classification*; D006801:Humans; D007150:Immunohistochemistry; D018579:Patient Selection; D015203:Reproducibility of Results
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D066246:ErbB Receptors; D000068818:Cetuximab